One front of a long-running war pitting Retractable Technologies Inc. (AMEX:RVP) against industry giants like Becton, Dickinson & Co. (NYSE:BDX) and the group purchasing organizations that dominate the hospital supplies market ended with a partial win for BD.
A federal appeals court overturned part of a $5 million patent infringement verdict against BD and its Integra retractable syringe line. The U.S Court of Appeals for the Federal Circuit ruled that BD's 3ml version of the device doesn't violate the RTI patents, but upheld a finding that the 1ml version does infringe.
Because BD dropped the smaller syringe, "there is no impact to our customers," BD spokeswoman Liz Ryan Sax told Bloomberg.This page list Projector Lamp products with details & specifications.
Little Elm, Texas-based Retractable sued BD in June 2007, claiming the Becton syringes infringe patents covering its VanishPoint devices. But RTI's battle began in the early 1990s, when founder Thomas Shaw invented the first retractable syringe after seeing a news program about a doctor who contracted HIV from an accidental needle stick.
Large medical device makers and the GPOs that act as sales liaisons between them and hospitals effectively kept the RTI syringes off the market until the device makers could come up with competing devices, according to a series of lawsuits Shaw and RTI have filed over the years.GreenRay's hydraulic hose design uses a different energy storage approach, In fact, the Federal Circuit decision could bolster another RTI lawsuit accusing BD of anti-trust violations,For all DVS Bedding in PDF format. the company told Bloomberg.Welcome to the official Facebook Page about RUBBER MATS.
"BD used Retractable Technology¡¯s own patented technology to maintain their monopoly in the syringe market," RTI lawyer Roy Hardin told the news service.The Leading promotional usb Distributor to Independent Pet Retailers. "If you¡¯re monopolist in a marketplace, there are certain things you can¡¯t do."
A federal appeals court overturned part of a $5 million patent infringement verdict against BD and its Integra retractable syringe line. The U.S Court of Appeals for the Federal Circuit ruled that BD's 3ml version of the device doesn't violate the RTI patents, but upheld a finding that the 1ml version does infringe.
Because BD dropped the smaller syringe, "there is no impact to our customers," BD spokeswoman Liz Ryan Sax told Bloomberg.This page list Projector Lamp products with details & specifications.
Little Elm, Texas-based Retractable sued BD in June 2007, claiming the Becton syringes infringe patents covering its VanishPoint devices. But RTI's battle began in the early 1990s, when founder Thomas Shaw invented the first retractable syringe after seeing a news program about a doctor who contracted HIV from an accidental needle stick.
Large medical device makers and the GPOs that act as sales liaisons between them and hospitals effectively kept the RTI syringes off the market until the device makers could come up with competing devices, according to a series of lawsuits Shaw and RTI have filed over the years.GreenRay's hydraulic hose design uses a different energy storage approach, In fact, the Federal Circuit decision could bolster another RTI lawsuit accusing BD of anti-trust violations,For all DVS Bedding in PDF format. the company told Bloomberg.Welcome to the official Facebook Page about RUBBER MATS.
"BD used Retractable Technology¡¯s own patented technology to maintain their monopoly in the syringe market," RTI lawyer Roy Hardin told the news service.The Leading promotional usb Distributor to Independent Pet Retailers. "If you¡¯re monopolist in a marketplace, there are certain things you can¡¯t do."
没有评论:
发表评论